SCHEMBL6525622

SCHEMBL6525622

Cc1cccc(N2C(=O)Cc3cc(F)ccc32)c1

nearest known ligand 0.56

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.56
KMT2A Q03164 3/20 0.56
GAA P10253 3/20 0.56
CASP6 P55212 2/20 0.56
L3MBTL1 Q9Y468 3/20 0.53
MAPT P10636 4/20 0.52
HSD17B10 Q99714 1/20 0.52
MGLL Q99685 2/20 0.46
HSP90AA1 P07900 1/20 0.46
HPGD P15428 1/20 0.45
PTGS1 P23219 1/20 0.41
PTGS2 P35354 1/20 0.41
ALDH1A1 P00352 4/20 0.40
POLB P06746 1/20 0.40
HTT P42858 1/20 0.40
P2RX7 Q99572 1/20 0.40
BCL2A1 Q16548 1/20 0.40
FAAH O00519 1/20 0.40
ACHE P22303 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10399819 0.81 HPGD (0.50) MEN1KMT2AGAACASP6MAPT
SCHEMBL2343941 0.78 HPGD (0.65) MEN1KMT2AGAACASP6L3MBTL1
SCHEMBL6767398 0.77 HPGD (0.68) MEN1KMT2AGAACASP6L3MBTL1
SCHEMBL6516492 0.76 RECQL (0.52) MEN1KMT2AGAACASP6L3MBTL1
SCHEMBL11965824 0.76 L3MBTL1 (0.51) MEN1KMT2AGAACASP6L3MBTL1
SCHEMBL16110144 0.75 MEN1 (0.52) MEN1KMT2AGAACASP6L3MBTL1
SCHEMBL8121918 0.74 L3MBTL1 (0.68) MEN1KMT2AGAACASP6L3MBTL1
SCHEMBL29702887 0.74 L3MBTL1 (0.68) MEN1KMT2AGAACASP6L3MBTL1
SCHEMBL10398763 0.72 HPGD (0.65) MEN1KMT2AGAACASP6L3MBTL1
SCHEMBL5218324 0.71 SLC6A2 (0.50) MEN1KMT2AGAAL3MBTL1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8680150-B2 Small molecule hematopoietic growth factor mimetic compounds that activate hematopoietic growth factor receptors LIGAND PHARMACEUTICALS, INC. (US) 2014-03-25 US disclosed
US-20110003851-A1 SMALL MOLECULE HEMATOPOIETIC GROWTH FACTOR MIMETIC COMPOUNDS THAT ACTIVATE HEMATOPOIETIC GROWTH FACTOR RECEPTORS LIGAND PHARMACEUTICALS, INC. (US) 2011-01-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110003851-A1 SMALL MOLECULE HEMATOPOIETIC GROWTH FACTOR MIMETIC COMPOUNDS THAT ACTIVATE HEMATOPOIETIC GROWTH FACTOR RECEPTORS MPL, CSF3R, CSF1R MEN1 1652/4885KMT2A 887/4885GAA 1623/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.